Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

66 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

Medical History Visit 04 SirTac NCT02936388 - Medical History Visit 04

- 26/11/2017 - 1 Formulário, 1 Grupo de itens, 9 Elementos de dados, 1 Idioma
Grupo de itens: Visit
Study part: Medical History Visit 04. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Medical History Visit 03 SirTac NCT02936388 - Medical History Visit 03

- 26/11/2017 - 1 Formulário, 2 Grupos de itens, 11 Elementos de dados, 1 Idioma
Grupos de itens: Visit, quality of life
Study part: Medical History Visit 03. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Medical History Visit 01 SirTac NCT02936388 - Medical History Visit 01

- 26/11/2017 - 1 Formulário, 1 Grupo de itens, 9 Elementos de dados, 1 Idioma
Grupo de itens: Visit
Study part: Medical History Visit 01. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Medical History Visit 02 SirTac NCT02936388 - Medical History Visit 02

- 26/11/2017 - 1 Formulário, 1 Grupo de itens, 9 Elementos de dados, 1 Idioma
Grupo de itens: Visit
Study part: Medical History Visit 02. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Day 0- Randomization SirTac NCT02936388 - Day 0- Randomization

- 26/11/2017 - 1 Formulário, 1 Grupo de itens, 8 Elementos de dados, 1 Idioma
Grupo de itens: Randomization
Study part: Day 0- Randomization. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Medical History Before every SIRT- or TACE- Treatment SirTac NCT02936388 - Medical History Before every SIRT- or TACE- Treatment

- 26/11/2017 - 1 Formulário, 2 Grupos de itens, 8 Elementos de dados, 1 Idioma
Grupos de itens: Symptoms, quality of life
Study part: Medical History Before every SIRT- or TACE- Treatment. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Comorbidity Screening Day -14 to 0 SirTac NCT02936388 - Comorbidity Screening Day -14 to 0

- 26/11/2017 - 1 Formulário, 1 Grupo de itens, 10 Elementos de dados, 1 Idioma
Grupo de itens: Comorbidity
Study part: Comorbidity Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Instrumental Diagnostics Screening Day -14 to 0 SirTac NCT02936388 - Instrumental Diagnostics Screening Day -14 to 0

- 26/11/2017 - 1 Formulário, 1 Grupo de itens, 14 Elementos de dados, 1 Idioma
Grupo de itens: Instrumental Diagnostics
Study part: Instrumental Diagnostics Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Medical History Screening Day -14 to 0 SirTac NCT02936388 - Medical History Screening Day -14 to 0

- 26/11/2017 - 1 Formulário, 2 Grupos de itens, 12 Elementos de dados, 1 Idioma
Grupos de itens: Medical History , previous therapy
Study part: Medical History Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Baseline MRI Screening Day -14 to 0 SirTac NCT02936388 - Baseline MRI Screening Day -14 to 0

- 20/11/2017 - 1 Formulário, 3 Grupos de itens, 13 Elementos de dados, 1 Idioma
Grupos de itens: Baseline MRI, location liver, Non-target Lesions
Study part: Baseline MRI Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Instrumental Diagnostics Screening Day -14 to 0 SirTac NCT02936388 - Instrumental Diagnostics Screening Day -14 to 0

- 20/11/2017 - 1 Formulário, 1 Grupo de itens, 14 Elementos de dados, 1 Idioma
Grupo de itens: Instrumental Diagnostics
Study part: Instrumental Diagnostics Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Medical History Screening Day -14 to 0 SirTac NCT02936388 - Medical History Screening Day -14 to 0

- 20/11/2017 - 1 Formulário, 2 Grupos de itens, 12 Elementos de dados, 1 Idioma
Grupos de itens: Medical History , previous therapy
Study part: Medical History Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial